SlideShare una empresa de Scribd logo
1 de 108
FRACTIONAL FLOW RESERVE
DR VISHWANATH HESARUR
SENIOR RESIDENT
DEPT OF CARDIOLOGY
JNMC, BELGAUM.
CORONARY BLOOD FLOW AND
MYOCARDIAL ISCHEMIA
UNIQUE FEATURES OF CORONARY BLOOD FLOW
• Phasic flow
• Transmural flow
• Extravascular compression
• Oxygen Extraction
Phasic flow
• Coronary perfusion – intermittent rather than
continuous
Determinants of Myocardial Oxygen Consumption
• In contrast to most other vascular beds, myocardial oxygen
extraction is near-maximal at rest, averaging 60% to 80% of
arterial oxygen content. So it might increase to maximum 90 %
after heavy exercise.
• Thus because of high resting tissue extraction of oxygen,
increase in the myocardial oxygen consumption ( MVo2)are
primarly met by a proportional increase in coronary blood flow.
• The major determinants of MVo2 are heart rate, systolic
pressure (or myocardial wall stress), and left ventricular (LV)
contractility.
• A twofold increase in any of these individual determinants of
MVo2 requires an approx 50% increase in coronary blood flow.
• Coronary blood flow at rest is Approx 250ml/min.
• Myocardium will regulate its own blood flow between perfusion
pressure of 40 to 140 mmhg, beyond this is pressure dependent.
Autoregulation
• Regional coronary blood flow remains constant as coronary
artery pressure is reduced below aortic pressure over a wide
range when the determinants of myocardial oxygen
consumption are kept constant.
• When pressure falls to the lower limit of autoregulation,
coronary resistance arteries are maximally vasodilated to
intrinsic stimuli, and flow becomes pressure-dependent,
resulting in the onset of subendocardial ischemia.
• The ability to increase flow above resting values in response to
pharmacologic vasodilation is termed coronary flow reserve.
• Transmural variations in the lower autoregulatory pressure
limit, which result in increased vulnerability of the
subendocardium to ischemia.
• Subendocardial flow occurs primarily in diastole and begins to
decrease below a mean coronary pressure of 40 mm Hg.
• By contrast, subepicardial flow occurs throughout the cardiac
cycle and is maintained until coronary pressure falls below 25
mm Hg.
• This difference arises from
– Increased oxygen consumption in the subendocardium.
– Higher resting flow rates
– Increased sensitivity to systolic compressive affects ie
subendocardial flow occurs only in diastole.
• The transmural difference in the lower autoregulatory pressure
limit results in vulnerability of the subendocardium to ischemia
in the presence of a coronary stenosis.
Determinants of Coronary Vascular Resistance
• The resistance to coronary blood flow can be divided into three major
components
• R1 ( Epicardial arteries )- Under normal circumstances, there is no measurable
pressure drop in the epicardial arteries, indicating negligible conduit
resistance.
• R2 ( Microcirculatory resistance arteries & arteriole (20 to 400 μm in
diameter)- distributed throughout the myocardium & respond to physical
forces (intraluminal pressure and shear stress), as well as the metabolic needs
of the tissue.
• R3 (Extravascular compressive resistance)- During systole, cardiac contraction
raises the extravascular pressure to values equal to LV pressure at the
subendocardium. This declines to values near pleural pressure at the
subepicardium.
• The increased effective back pressure during systole produces a time varying
reduction in the driving force for the coronary flow that impedes the coronary
flow to subendocardium.
• In heart failure compressive effects from elevated ventricular diastolic
pressures also impede perfusion via passive compression by increasing extra
vascular tissue pressure during diastole.
Physiological assesment of coronary artery stenosis
• The physiologic assessment of stenosis severity is a critical
component of the management of patients with obstructive
epicardial CAD.
• Stenosis in the epicardial artery result in reduced perfusion
pressure , arterioles downstream dilate to maintain normal
resting flow .
• As stenosis progress, arteriolar dilatation becomes chronic,
decreasing potential to augment flow and thus reduce coronary
flow reserve.
• As CFR approaches to 1, any further decrease in perfusion
pressure or increase in MV02 result in ischemia.
• The total pressure drop across a stenosis is
governed by three hydrodynamic factors —
viscous losses, separation losses, and
turbulence.
The Coronary Pressure–Flow
Relationships
• Myocardial ischemia results from an imbalance
between myocardial oxygen supply and demand.
• Coronary blood flow provides the needed oxygen
supply for any given myocardial oxygen demand and
normally increases automatically from a resting
level to a maximum level in response to increases in
myocardial oxygen demand from exercise and
neurohumoral or pharmacological hyperemic
stimuli.
• This increase from baseline to maximal flow has
been termed coronary flow reserve (CFR).
• Blood flow has 3 major resistance components: the epicardial
vessel (R1), the small arteries and arterioles (R2), and the
intramyocardial capillary system (R3).
• When coronary reserve is normal, these 3 resistances are
assumed to be functioning normally.
• In patients without atherosclerosis, the large epicardial vessel
resistance (R1) is trivial.
• Arteries with diameters 400 um have only minimal resistance.
• Adjustment of coronary resistance occurs principally at the R2
resistance (vessels 400 um in diameter) and is due to the
integrated action of several control mechanisms.
• Across a normal epicardial artery, supplying normal
myocardium, coronary blood flow can increase 3-fold in adults.
• Autoregulation automatically maintains the
basal flow at a constant level in response to
changing pressure and oxygen demand.
• Atherosclerotic narrowings produce epicardial
vessel resistance and, after a critical reduction
in vessel lumen area, can abolish not only
coronary reserve but also autoregulation, thus
reducing resting coronary blood flow.
• Coupled with reduced flow is the loss of
pressure distal to a stenosis.
• The resistance to flow
through a stenosis
caused by viscous
friction, flow
separation, turbulence,
and eddies at the site of
the stenosis results in
energy loss.
• Energy loss produces
pressure loss distal to
the stenosis and thus a
pressure gradient across
the narrowed segment
(Figure 1).
• The pressure loss or
gradient increases
with increasing
coronary flow along
a quadratic pressure
drop–flow
relationship of the
specific coronary
stenosis
• In vessels without a
stenosis, the
pressure–flow curve
of maximal
vasodilation is
linear in the
physiological
pressure range .
• However, when a stenosis is present, the maximal flow
at any given arterial pressure is lower.
• In this setting, the coronary pressure–flow line at
maximum vasodilation is no longer straight but
curvilinear because stenosis resistance is flow
dependent.
• The clinical significance of these observations is that 2
nearly identical angiographic stenoses (eg, 60%
diameter narrowing) can have a dramatically different
clinical impact for the patient.
• One stenosis would limit flow for increasing demand
and would produce angina, whereas the other would be
angiographically apparent but would remain clinically
unimportant
Coronary Pressure and Fractional
Flow Reserve
• Myocardial perfusion pressure, normally the diastolic
coronary pressure, equals aortic pressure minus the left
ventricular diastolic pressure or central venous pressure.
• Across normal coronary arteries, aortic pressure is
transmitted completely, without appreciable pressure
loss even to the most distal regions.
• As noted earlier, the distal coronary pressure in arteries
with an atherosclerotic narrowing is decreased in
relationship to the degree of stenosis resistance.
• Pijls et al related the distal coronary pressure to the
ischemic potential of a stenosis by calculating a value
called the fractional flow reserve (FFR).
• By taking the ratio of the coronary pressure
measured distal to the stenosis to aortic pressure as
the normal perfusion pressure (distal coronary
pressure/aortic pressure) and obtaining these
measurements when the microvascular resistance
was minimal and assumed to be constant (that is, at
maximal hyperemia), the percentage of normal
coronary flow, or a fraction of normal flow (ie, FFR),
can be calculated.
• The FFR measures the maximum achievable
myocardial blood flow in the presence of a coronary
artery stenosis as a percentage of the maximum
blood flow in the hypothetical case of a completely
normal artery
• FFR model assumes that under maximum arterial
vasodilation, the resistance of the myocardium is
minimal and constant across different myocardial
vascular beds, and thus blood flow to the
myocardium is proportional to the driving pressure
(myocardial perfusion pressure).
• FFR can be derived separately for the myocardium,
for the epicardial coronary artery, and for the
collateral supply.
• Calculations of myocardial, coronary, and collateral
FFR from pressure measurements taken during
maximal arterial vasodilation (ie, hyperemia) are as
follows:
• The FFR is simplified to Pd/Pa given the
assumption that Pv is negligible relative to Pa.
• An FFR value of 0.6 means that the
maximum myocardial flow across the
stenosis is only 60% of what it should be
without the stenosis.
• An FFR of 0.9 after percutaneous coronary
intervention (PCI) means that the
maximum flow to the myocardium is 90%
that of a completely normal vessel.
• FFR has a normal value of 1.0 for every
patient and every coronary artery.
• An FFR 0.75 is associated with inducible
ischemia (specificity, 100%), whereas a
value 0.80 indicates absence of inducible
ischemia in the majority of patients
(sensitivity, 90%).
Fractional Flow Reserve
• Based on the principle that the distal coronary
pressure measured during vasodilation is directly
proportional to maximum vasodilated perfusion.
• FFR is defined as the ratio of maximum blood flow
in a stenotic artery to maximum blood flow in the
same artery if there were no stenosis.
• FFR is simply calculated as a ratio of mean pressure
distal to a stenosis (Pd) to the mean pressure
proximal stenosis, that is the mean pressure in the
aorta (Pa), during maximal hyperaemia.
LIMITATIONS OF CORONARY ANGIOGRAPHY
– Interpretation is highly subjective
– CAG provides a 2–dimentional view of a 3-dimensional
lumen.
– Severity of a stenotic lesion is reported in comparison to a
normal reference segment . This is particularly fallacious in
case of diffuse disease.
– CAG is a lumenography & does not provide information
regarding vessel wall & extent of positive or negative
remodeling.
– An ecentric stenosis has varying appearance of severity in
different views. The length, size and severity of a lesion & its
relationship with the vessel wall can affect the coronary flow.
– Several artifacts contribute to the disparity in interpretation
like vessel foreshortening, overlapping vessels, calcification
& contrast streaming.
TECHNIQUE
Catheter
• Diagnostic catheters can not be used to measure FFR -
pressure measurements can be inaccurate & the wire
manipulation is met with friction due to smaller internal
diameters compared to guide catheters.
• The main advantage of using guide catheters is that PCI
is immediately possible if required.
• Guide catheter with Side holes should not be used
– It can create a false gradient between the side holes & the tip
of the guide catheter creating a false Positive FFR.
– Pharmacological vasodilatory agents may be flushed into the
aorta instead of the coronary artery.
Pressure Wire
• Two pressure wires are available namely
PressureWire ( st Jude medical, MN, USA) &
Volcano WaveWire ( Volcano Inc,
CA,USA)
• Both have the pressure sensor (solid-state
(electronic) sensor) located at the junction of
the radiopaque & radiolucent part of the wire,
30 mm from the tip.
• The wires are 0.014-inch (0.33-mm) floppy-
tipped guide wire
36
PressureWire®
The distal pressure in the coronary artery is measured by a tiny sensor
located 3 cm from the tip of an 0.014” guidewire, called PressureWire®.
0.014”
3 cm
Pressure Monitoring Guide Wire
Maximal Hyperaemia
• Epicardial & resistance arteries have to be
vasodilated.
• Epicardial vessels are dilated using a bolus of
100-200 mcg of intracoronary nitroglycerine at
least 30 seconds before the first measurement.
• Hyperaemia is induced in the resistance
vessels using adenosine ( IC or IV ) or
papaverine ( IC )
IV vs IC PHARMACOLOGIC HYPEREMIC AGENTS
Maximum Hyperemia
Horizontal Pd/Pa line:
Steady State and likely
Maximum Hyperemia
Anticoagulation
• Standard protocols for anticoagulation should
be followed.
• Heparin is administered according to body
weight to maintain an ACT of at least 250.
• Display
• The pressure wire is connected to an interface
( Analyzer Express, St Jude medical inc. or
combomap, volcano Inc.) which shows the
mean Aortic pressure (Pa) & the mean pressure
at the tip of the guide wire (Pd) simultaneously
& provides a FFR value immediately.
42
RadiAnalyzer®
PressureWire® is attached to RadiAnalyzer®, an interface which makes
the FFR calculations automatically during the procedure.
It displays both aortic and distal pressure wave forms.
Cathlab
recording
system
PressureWire
AO transducer
IBPinput
FFR
Precautions
• Guiding catheter should not have side holes
• Introducer needle should be removed before
equalising or taking measurements.
• Equalise the pressure measured by the
pressure wire & guiding catheter.
• Height of the transducer should be adjusted to
the patients heart level.
• Appropriate dose & route of pharmacological
agents to achieve maximal hyperaemia is
essential to obtain accurate results
• Use central vein for IV adenosine.
Pressure Measurement
Step 1: Zero the Pressure System to the
Atmosphere
Step 2: Insert the Pressure Sensor Guide
Wire Into the Guide and Equalize the 2
Pressures
Step 3: Advance the Pressure Wire Sensor
Distal to the Region of Interest
Step 4: Induce Maximal Hyperemia
Step 5: Wire Pullback to Check for Signal
Drift
0
100
50
Pa = Guiding Catheter
Pd = Pressure Wire
Pressure Monitoring Guide Wire
UNIQUE FEATURES OF FFR
• Normal value of 1 irrespective of the patient , artery or
vascular bed. It is independent of gender & other factors like
DM & HTN
• Well defined cut-off values :
– FFR values ≤ 0.75 is invariably associated with inducible ischemia
(sensitivity 88%, specificity 100%, positive predictive value 100% & overall
accuracy 93%)
– FFR ≥0.80 is usually not associated with inducible ischemia.
– The gray zone of 0.75 to 0.80 spans over a small range of FFR values.
• Systemic haemodynamics like heart rate , blood pressure &
LV contractility do not affect the value of FFR since the value
of Pd & Pa are taken simultaneously.
• Reproducibility : FFR is reproducible since the
microvasculature has the capacity to vasodilate the same
extent repeatedly.
• Contribution of collateral vessels is taken in to
account. The pressure distal to the stenosis is
influenced by antegrade flow & retrograde flow & is
therefore influenced by a stenotic vessel supplied by
collateral & a stenotic vessel giving collaterals to a
more severely stenosed vessel.
• Spatial resolution
– During maximal hyperaemia, pulling back the pressure
wire can provide an instantaneous measure of the
signifance of a particular segment of the coronary
artery with a spatial resolution of a few millimeters.
– It therefore provides a per segment analysis of the
coronary artery.
– This is especially useful in case of sequential stenosis to
determine the stenosis with the maximum
haemodynamic significance.
• Relation between FFR & viable myocardium :
– If a stenotic vessel supplies a larger viable myocardial mass, there
will be larger hyperaemic flow during maximal vasodilation
resulting in a greater gradient between Pd & Pa & thus , a lower
value of FFR.
– Therefore , the haemodynamic significance of a lesion is
dependent on its perfusion territory.
APPLICATIONS OF FFR IN SPECIFIC
SUBSETS
Intermediate lesions
• Intermediate lesions with a FFR of ≥ 0.80 can be safely defered.
• The DEFER study has shown that patients with single vessel
stenosis and FFR >0.75 who did not undergo PCI had excellent
outcomes.
• The risk of cardiac death or MI related to the stenosis was < 1%
per year and was not reduced with PCI.
• In contrast, patients with single-vessel stenosis and FFR <0.75
are 5× more likely to experience cardiac death or MI within 5
years, despite undergoing revascularization.
• Deferral of revascularization for single-vessel
stenoses according to the FFR value is safe
regardless of the stenosis location.
• Muller et al showed that medical treatment of
patients with proximal left anterior descending
stenoses and FFR >0.80 had excellent 5-year
outcomes.
• Even for patients with small coronary arteries
(diameter <2.8 mm), FFR can safely determine
stenoses that necessitate revascularization.
• Physiologic and Anatomical Evaluation Prior to and After Stent
Implantation in Small Coronary Vessels (PHANTOM) trial,
– 60 patients with small coronary arteries underwent FFR.
– 56 of the 60 patients had undergone IVUS.
– Patients were stratified according to FFR (<0.75 and >0.75).
– The group with FFR <0.75 underwent revascularization.
– At 1 year, there was no occurrence of MI or death in either
group.
– In patients with FFR <0.75, 24% underwent a repeat PCI, but
only 2.6% of patients with FFR >0.75 underwent
revascularization.
– Overall, there was no correlation between FFR and IVUS.
Multivessel Coronary Artery Disease
• FFR has a major impact on the revascularisation strategy in
multivessel disease .
• In patients who have triple vessel disease , FFR may demonstrate
haemodynamically significant stenosis of only two vessels.
• Conversely , a patient with apparently one or two vessel disease may
have a haemodynamic significant lesion in LM artery or in all three
vessels.
• This can affect the decision of PCI versus surgical revascularisation &
also the number of stents used during PCI.
• The FAME study showed a reduced rate of mortality & MI after 2 yrs
in the subset with FFR guided PCI, in patients with multivessel
disease.
Ref. NEJM Vol 360, No 3, pp 213-224. Slides courtesy Nico H J Pijls.
FAME study: Study Population
The FAME study was designed to reflect daily practice
in performing PCI in patients with multivessel disease
Inclusion criteria:
• ALL patients with multivessel disease
• At least 2 stenoses ≥ 50% in 2 or 3 major epicardial
coronary artery disease, amenable for stenting
Exclusion criteria:
• Left main disease or previous bypass surgery
• ST-elevation MI with CK > 1000 U/l within last 5 days
• extremely tortuous or calcified coronary arteries
Note: patients with previous PCI were not excluded
• CONCLUSIONS:
Routine measurement of FFR in patients
with multivessel disease (MVD) who are
undergoing PCI with drug-eluting stents
(DES) significantly improves outcomes at 1
year by reducing MACE (composite rate of
death, nonfatal myocardial infarction, and
repeat revascularization)
FAME II: Fractional Flow Reserve-Guided Percutaneous Coronary
Intervention plus Optimal Medical Treatment versus Optimal
Medical Treatment Alone in Patients with Stable Coronary Artery
Disease
73% 50% randomly
assigned to FU27%
Registry
When all FFR > 0.80
(n=332)
MT
Randomized Trial
At least 1 stenosis
with FFR ≤ 0.80 (n=888)
Randomization 1:1
PCI + MT MT
Follow-up after 1, 6 months, 1, 2, 3, 4, and 5 years
De Bruyne B, et al. N Engl J Med. 2012 Sep13;367(11):991-1001.
FAME 2 Study Flow Chart
Stable CAD patients scheduled for 1, 2 or 3 vessel DES-PCI
N = 1220
FFR in all target lesions
Cumulativeincidence(%)
FAME 2: Primary Outcomes
Death, MI, Urgent Revascularization
30
25
20
15
10
5
0
441
447
166
414
414
156
370
388
145
322
351
133
283
308
117
253
277
106
220
243
93
192
212
74
162
175
64
127
155
52
100
117
41
70
92
25
37
53
13
MT
PCI+MT
Registry
No. at risk
0 1 2 3 4 5 6 7 8 9 10 11 12
Months after randomization
PCI+MT vs. MT:
PCI+MT vs. Registry:
MT vs. Registry:
HR 0.32 (0.19-0.53); p<0.001
HR 1.29 (0.49-3.39); p=0.61
HR 4.32 (1.75-10.7); p<0.001
De Bruyne B,et al. N Engl J Med. 2012 Sep 13;367(11):991-1001.
FAME 2: Primary Outcomes
Primary Endpoint
Death
Myocardial Infarction
Urgent Revascularization
Free from Angina (1 month)
FFR-Guided PCI
(n=447)
4.3%
0.2%
3.4%
1.6%
89%
MT
(n=441)
12.7%
0.7%
3.2%
11.1%
71%
P-Value
<0.001
0.31
0.89
<0.001
<0.001
De Bruyne B,et al. N Engl J Med. 2012 Sep 13;367(11):991-1001.
FAME 2 TRIAL
• Conclusion
• In patients with stable coronary artery disease and
at least one stenosis with an FFR≤0.80, OMT alone
was associated with a more than fourfold larger
hazard of major adverse cardiac events than FFR-
guided PCI with drug-eluting stents plus OMT.
• In contrast, in patients with hemodynamically non-
significant stenoses (FFR>0.80), OMT alone was
associated with a favourable clinical outcome.
Left-Main Coronary Artery Disease
• Left main coronary artery poses certain challenges
which make the interpretation of CAG & severity of
stenosis difficult.
– Greater inter-observer variability
– Under-estimation of functional significance since it supplies
a large myocardial territory
– Diffuse atherosclerosis in a short LMCA results in absence of
a reference segment to judge the significance of a lesion
– Spilling of contrast medium in to the aorta
– Overlapping the catheter with the LMCA
– Non – invasive testing may lead to false negative results since
reduced tracer uptake in all vascular territories leading to
balanced ischemia.
– FFR has been found to be safe in guiding LMCA
revascularisation in several studies & is associated with
improved outcomes.
Tandem Lesions
• Tandem lesions are defined as 2 separate lesions with
>50% stenosis each in the same coronary artery,
separated by an angiographically normal segment.
• If the FFR is<0.75, Hirota et al suggested performing PCI
for the stenosis that showed marked narrowing first and
then repeating the FFR measurement.
• If the FFR remains <0.75, the other stenosis was
revascularized as well; in contrast, if the FFR value of the
first lesion increased after PCI to >0.75, then the second
lesion was treated only medically
Treat lesion 2,
Final FFR
J Am Coll Cardiol Intv.
2012;5(10):1013-1018.
Considerations for Serial lesions
Pre FFR (1+2) with
pullback
Lesion 1 large dP,
Stent
Recheck FFR
• Lesion with largest pressure drop was
stented first (116 total stents, 70 proximal,
46 distal)
• Strategy not clearly stated but seems like
goal was to achieve post stent FFR > 0.80
• Revascularization deferred in 61% lesions
• ≥2 stents deployed in only 18% vessels
N=298 Lesions, at least 20 mm apart, either chronic CAD or no
Kim et al. J Am Coll Cardiol Intv 2012;5:1013-8
FFR Guided PCI of Serial Lesions
N=131 Patients with multiple 40-70% stenoses, 2 centers
Bifurcation lesions
• Bifurcation lesions are particularly difficult to evaluate
by angiography.
• After stenting the main vessel, the side branch appears
pinched which is grossly overestimated by angiography
• Koo et al showed that kissing balloon dilatation of the
ostial side branch lesions with FFR < 0.75 only , resulted
to a FFR > 0.75 in 95% patients after 6 months.
• If the FFR of an apparently pinched side branch is >0.75,
it can safely be left alone.
FFR in Bifurcation Disease
N = 110 patients with FFR guided bifurcation PCI with DES
compared with 110 matched angiographic guided bifurcation
PCI
Koo et al., European Heart Journal 2008 29(6):726-732
FFR in Bifurcation Disease
N = 26 patients with FFR guided side branch PCI with DES with
baseline and follow up FFR
Koo et al., European Heart Journal 2008 29(6):726-732
Post stenting
• Nico H.J. Pijls at al showed that FFR
measured after stenting should be >0.90 &
is an independent predictor of 6 month
mortality.
• The registry was performed in 750 patients
in 15 hospitals in 8 countries (5 centers in
the United States, 5 centers in Europe, and
5 centers in Asia).
Coronary Pressure Measurement After Stenting Predicts
Adverse Events at Follow-Up
A Multicenter Registry, (Circulation. 2002;105:2950-
2954.)
CABG conduit patency
• 20-25 % of grafts done to physiologically
nonsignificant lesions ( FFR > 0.80) were found to
be occluded at 1 yr.
• This occurs because blood flow favors a path of
lower resistance through the native vessel with a
nonsignificant obstruction as compared to a vein
graft.
• Thus FFR can provide information about future
graft patency & allows an appropriate selection of
the vessel which should not be grafted
Graft intervention
• FFR can be used to determine the
physiological significance of a lesion in a
graft vessel.
• The same cut off af ≤ 0.75 has been used in
a small study comparing FFR to stress
myocardial perfusion imaging with an
acceptable specificity & negative predicitive
value.
PITFALLS OF FFR
Hemodynamic Artifacts
• Damped pressure waveforms.
• Guide obstruction
• Contrast media
• Very small guide (<5F)
• Pressure signal drift
• Side holes and ostial
‘pseudostenosis’
Technical
• loose connections
• Improper zero
• Calibration offset
Anatomic
• Extreme tortuosity
• Inability to wire vessel
• Spasm
Mechanical
Wire/artery impact
Pharmacologic
Inadequate hyperemia
Effect of Wire Introducer
Guiding catheter related
• Small ostium, too large guiding catheter
• Solve by dislodging guiding and using iv adenosine
guiding in ostium
guiding out ostium
Impact of Catheter Size on Hyperemic Flow
De Bruyne, et al. Cathet Cardiovasc Diagn 1994;33:145-152.
Pd
Pc
FFR and Guidings with Side-Holes
Pa
Pressure recorded by guiding
PaPc =
When wedging of the catheter, withdraw guiding from ostium
For flow or pressure measurements:
NO SIDE-HOLES
Side Holes
Sensor proximal to side holes
Guiding Catheter With Sides Holes
Notch
Notch
No notch
Drift Drift True Gradient
Notch
CONCLUSION
• FFR strongly supports the concept of 'Functionally Complete
Revascularisation', that is stenting of the physiologically significant
ischemic stenosis & medical management of the non-ischemic
stenosis .
• In spite of the strong evidence favoring its use, FFR is still not used
widely .
• The application of FFR along with angiography combines two gold
standard investigations to provide an all in one anatomical &
physiological assessment of CAD.
• Its application in various subsets of coronary artery anatomies make
FFR an essential tool in the cath lab ,in decision making & improving
outcomes of patients undergoing PCI.
Coronary Flow and Flow Reserve
• As stenosis severity increases, maximal
coronary flow becomes attenuated and CFR
decreases.
• CFR is a combined measure of the capacity
of the major resistance components (the
epicardial coronary artery and supplied
vascular bed) to achieve maximal blood
flow in response to hyperemic stimulation.
• A normal CFR implies that both the epicardial and
minimally achievable microvascular bed resistances
are low and normal.
• However, when abnormal, CFR does not indicate
which component is affected, thus limiting the
clinical applicability of this measurement.
• Although early studies in animals and patients
suggested an absolute CFR of 3.5 to 5 in adult
patients with chest pain syndromes and CAD risk
factors undergoing cardiac catheterization with
angiographically normal vessels, the normal CFR
was 2.70 to 6 which suggests a degree of patient
variability and microvascular disease.
• In patients with essential hypertension and normal
coronary arteries or in patients with aortic stenosis
and normal coronary arteries, CFR may be reduced,
in part because of myocardial hypertrophy and an
abnormal microvasculature.
• CFR can be altered by changes in either basal or
hyperemic flow, which are influenced by
hemodynamics, loading conditions, and
contractility.
• For example, tachycardia increases basal flow and
decreases hyperemic flow, thus reducing CFR 10%
for each 15-beat increase in heart rate.
• Because CFR is a summed response of both the epicardial and
microvascular flow, clinicians are reluctant to use CFR as the
sole indicator of lesion significance except when it is normal.
• To increase confidence in CFR as a measure of lesion severity,
the determination of relative CFR (rCFR) has been proposed by
Gould et al,3 who defined rCFR as the ratio of maximal flow in a
coronary artery with stenosis (QS) to maximal flow in a normal
coronary artery without a stenosis (QN).
• It was shown that rCFR was independent of the aortic pressure
and rate–pressure product and was well suited to assess the
physiological significance of coronary stenoses when an
adjacent nondiseased coronary artery was available
• For invasive catheterization laboratory flow studies, rCFR was
defined as the ratio of CFRtarget to CFRnormal reference vessel:
• The normal range for rCFR is 0.8 to 1.0.
• Because of the variability of CFR and limitations in patients with
multivessel CAD, rCFR is not commonly used.
• Likewise, rCFR relies on the assumption that the microvascular
circulatory response is uniformly distributed among the myocardial
beds; thus, rCFR is of no value in patients with myocardial infarction
(MI) or left ventricular regional dysfunction or in patients in whom the
microcirculatory responses may be heterogeneous (eg, those with
myocardial fibrosis or asymmetric hypertrophy).
• In clinical terms, CFR is best used to assess the microcirculation in the
absence of epicardial artery narrowings.
• CFR is not used to assess stenosis significance because of the influence
of hemodynamics and the unknown impact of the microcirculation.
Rentrop Grade of Collateral
Filling
• Rentrop et al. proposed the system below to grade collateral filling of
recipient arteries:
• Rentrop Grade 0
No visible filling of any collateral channels.
• Rentrop Grade 1
Collateral filling of branches of the infarct related artery.
• Rentrop Grade 2
Partial collateral filling of the epicardial segment of the infarct related
artery .
• Rentrop Grade 3
Complete collateral filling of the infarct related artery.
Laminar flow
• Laminar flow is the normal condition for blood flow throughout most
of the circulatory system.
• It is characterized by concentric layers of blood moving in parallel
down the length of a blood vessel.
• The highest velocity (Vmax) is found in the center of the vessel.
• The lowest velocity (V=0) is found along the vessel wall.
• The flow profile is parabolic once laminar flow is fully developed. This
occurs in long, straight blood vessels, under steady flow conditions.
• One practical implication of parabolic, laminar flow is that when flow
velocity is measured using a Doppler flowmeter, the velocity value
represents the average velocity of a cross-section of the vessel, not the
maximal velocity found in the center of the flow stream.
• The orderly movement of adjacent layers of blood flow through a
vessel helps to reduce energy losses in the flowing blood by
minimizing viscous interactions between the adjacent layers of blood
and the wall of the blood vessel.
• Disruption of laminar flow leads to turbulence and increased energy
losses.
Turbulent Flow
• Generally in the body, blood flow is laminar. However, under
conditions of high flow, particularly in the ascending aorta,
laminar flow can be disrupted and become turbulent.
• When this occurs, blood does not flow linearly and smoothly in
adjacent layers, but instead the flow can be described as being
chaotic.
• Turbulent flow also occurs in large arteries at branch points, in
diseased and narrowed (stenotic) arteries (see figure below),
and across stenotic heart valves.
• Turbulence increases the
energy required to drive
blood flow because
turbulence increases the loss
of energy in the form of
friction, which generates
heat.
• When plotting a pressure-
flow relationship (see figure
to right), turbulence increases
the perfusion pressure
required to drive a given flow.
• Alternatively, at a given
perfusion pressure,
turbulence leads to a decrease
in flow.
Viscosity of Blood
• Viscosity is an intrinsic property of fluid related to the internal friction of
adjacent fluid layers sliding past one another
• This internal friction contributes to the resistance to flow.
• The interactions between fluid layers depend on the chemical nature of the
fluid, and whether it is homogeneous or heterogeneous in composition.
• For example, water is a homogeneous fluid and its viscosity is determined by
molecular interactions between water molecules.
• Water behaves as a Newtonian fluid and therefore under non-turbulent
conditions, its viscosity is independent of flow velocity (i.e., does not change
with changes in velocity).
• Although plasma is mostly water, it also contains other molecules such as
electrolytes, proteins (especially albumin and fibrinogen), and other
macromolecules.
• Because of various molecular interactions between these many different
components of plasma, it is not surprising that plasma has a higher viscosity
than water.
• In fact, plasma at 37°C is about 1.8-times more viscous than water at the same
temperature; therefore, the relative viscosity of plasma (compared to water)
is about 1.8.
• The addition of formed elements to the plasma (red cells, white cells, and
platelets) further increases the viscosity.
• Of these formed elements, red cells have the greatest effect on viscosity under
normal conditions.
• As shown in the figure to the right in which whole blood viscosity is
determined in vitro using a viscometer, an increase in red cell hematocrit
leads to an increase in relative viscosity.
• Note that the increase is non-linear, so that doubling hematocrit more than
doubles the relative viscosity.
• Therefore, blood viscosity strongly depends on hematocrit.
• At a normal hematocrit of 40-45%, the relative viscosity of blood is 4-5.
• Patients with a condition called polycythemia, which is a abnormal elevation
in red cell hematocrit, have much higher blood viscosities.
• This increases the resistance to blood flow and therefore increases the work of
the heart and can impair organ perfusion.
• Some patients with anemia have low hematocrits, and therefore reduced
blood viscosities.
• A second important factor that influences blood viscosity is
temperature.
• Just like molasses, when blood gets cold, it get "thicker" and flows
more slowly.
• Therefore, there is an inverse relationship between temperature and
viscosity.
• Viscosity increases about 2% for each degree centigrade decrease in
temperature.
• Normally, blood temperature does not change much in the body.
However, if a person's hand is exposed to a cold environment and the
fingers become cold, the blood temperature in the fingers will fall and
viscosity increase, which together with sympathetic-mediated
vasoconstriction will decrease blood flow in the cooled region.
• When whole body hypothermia is induced in critical care or surgical
situations, this will also lead to an increase in blood viscosity and
therefore affect systemic hemodynamics and organ blood flow.
• Unlike water, blood is non-Newtonian, meaning
that viscosity is not independent of flow at all flow
velocities. In fact, during conditions such as
circulatory shock where microcirculatory flow in
tissues is reduced because of decreased arterial
pressure, low flow states can lead to several-fold
increases in viscosity. Low flow states permit
increased molecular interactions to occur between
red cells and between plasma proteins and red cells.
This can cause red cells to stick together and form
chains of several cells (rouleau formation) within
the microcirculation, which increases the blood
viscosity.
• If clotting mechanisms are stimulated in
the blood, platelet aggregation and
interactions with plasma proteins occur.
This leads to entrapment of red cells and
clot formation, which dramatically increase
blood viscosity.
• There is a microcirculatory phenomenon called the Fahraeus-
Lindqvist effect that leads to a reduction in hematocrit in
small arterioles (less than 200 microns in diameter) and
capillaries relative to the hematocrit of large feed arteries. This
decrease in hematocrit in these flow vessels reduces the relative
blood viscosity in the small vessels, which helps to offset the
increase in viscosity that can occur because of reduced velocity
in these same vessels. The net effect of these changes is that
blood flow in the microcirculation has a lower viscosity than
what is predicted by in vitro blood viscometer measurements. In
vivo measurements of blood viscosity were made in dog
hindlimbs in 1933 by Whittaker and Winton (J. Physiol. 78:339,
1933). At a given arterial blood hematocrit, the relative viscosity
of blood is much lower than predicted from in vitro experiments
(compare figure at right with previous figure that used a
viscometer).
FRACTIONAL FLOW RESERVE

Más contenido relacionado

La actualidad más candente

La actualidad más candente (20)

Cath hemodynamics vir
Cath hemodynamics virCath hemodynamics vir
Cath hemodynamics vir
 
Fraction flow reserve
Fraction flow reserveFraction flow reserve
Fraction flow reserve
 
Rotablation
RotablationRotablation
Rotablation
 
Trans septal puncture
Trans septal punctureTrans septal puncture
Trans septal puncture
 
Ffr
FfrFfr
Ffr
 
Right heart catheters
Right heart cathetersRight heart catheters
Right heart catheters
 
CORONARY BALLOONS PRACTICAL ASPECTS.pptx
CORONARY BALLOONS PRACTICAL ASPECTS.pptxCORONARY BALLOONS PRACTICAL ASPECTS.pptx
CORONARY BALLOONS PRACTICAL ASPECTS.pptx
 
Coronary guide wires
Coronary guide wires  Coronary guide wires
Coronary guide wires
 
Assessment of prosthetic valve function
Assessment of prosthetic valve functionAssessment of prosthetic valve function
Assessment of prosthetic valve function
 
Cardiac Resynchronization therapy.pptx
Cardiac Resynchronization therapy.pptxCardiac Resynchronization therapy.pptx
Cardiac Resynchronization therapy.pptx
 
PBMV:Tips and Tricks
PBMV:Tips and TricksPBMV:Tips and Tricks
PBMV:Tips and Tricks
 
Cardiac dyssynchrony ppt by dr awadhesh
Cardiac dyssynchrony ppt   by dr awadheshCardiac dyssynchrony ppt   by dr awadhesh
Cardiac dyssynchrony ppt by dr awadhesh
 
Aortic stenosis - Echocardiography
Aortic stenosis - EchocardiographyAortic stenosis - Echocardiography
Aortic stenosis - Echocardiography
 
PTMC/PBMC
PTMC/PBMCPTMC/PBMC
PTMC/PBMC
 
Stent Thrombosis
Stent ThrombosisStent Thrombosis
Stent Thrombosis
 
Echo assessment of RV function
Echo assessment of RV functionEcho assessment of RV function
Echo assessment of RV function
 
Management of no reflow
Management of no reflowManagement of no reflow
Management of no reflow
 
Echo assessment of mitral regurgitation
Echo assessment of mitral regurgitationEcho assessment of mitral regurgitation
Echo assessment of mitral regurgitation
 
ECHO ASSESSMENT OF ASD FOR DEVICE CLOSURE
ECHO ASSESSMENT OF ASD FOR DEVICE CLOSURE ECHO ASSESSMENT OF ASD FOR DEVICE CLOSURE
ECHO ASSESSMENT OF ASD FOR DEVICE CLOSURE
 
PVBD
PVBDPVBD
PVBD
 

Similar a FRACTIONAL FLOW RESERVE

2 systemic circulation.pptx
2 systemic circulation.pptx2 systemic circulation.pptx
2 systemic circulation.pptx
reham673187
 

Similar a FRACTIONAL FLOW RESERVE (20)

FFR RAMDHAN.pptx
FFR RAMDHAN.pptxFFR RAMDHAN.pptx
FFR RAMDHAN.pptx
 
Coronary blood flow
Coronary blood flowCoronary blood flow
Coronary blood flow
 
CORONARY BLOOD FLOW
CORONARY BLOOD FLOWCORONARY BLOOD FLOW
CORONARY BLOOD FLOW
 
Coronary blood flow
Coronary blood flowCoronary blood flow
Coronary blood flow
 
Coronary Blood Flow and Myocardial Ischemia.pptx
Coronary Blood Flow and Myocardial Ischemia.pptxCoronary Blood Flow and Myocardial Ischemia.pptx
Coronary Blood Flow and Myocardial Ischemia.pptx
 
Coronary circulation
Coronary circulationCoronary circulation
Coronary circulation
 
CARDIOVASCULAR PHYSIOLOGY -2.rajesh munigial
CARDIOVASCULAR PHYSIOLOGY -2.rajesh munigialCARDIOVASCULAR PHYSIOLOGY -2.rajesh munigial
CARDIOVASCULAR PHYSIOLOGY -2.rajesh munigial
 
hemorrage brain Kasturba Hospital manipal
hemorrage brain Kasturba Hospital manipalhemorrage brain Kasturba Hospital manipal
hemorrage brain Kasturba Hospital manipal
 
CABG from zero to hero Physiology introduction.
CABG from zero to hero Physiology introduction.CABG from zero to hero Physiology introduction.
CABG from zero to hero Physiology introduction.
 
coronarycirculation. and peculiarities,regulationpptx
coronarycirculation. and peculiarities,regulationpptxcoronarycirculation. and peculiarities,regulationpptx
coronarycirculation. and peculiarities,regulationpptx
 
Physiology of coronary blood flow
Physiology of coronary blood flow Physiology of coronary blood flow
Physiology of coronary blood flow
 
Cardiac physiology
Cardiac physiologyCardiac physiology
Cardiac physiology
 
lecture 2- 1 Cardiovascular.pptx
lecture 2- 1 Cardiovascular.pptxlecture 2- 1 Cardiovascular.pptx
lecture 2- 1 Cardiovascular.pptx
 
Coronary circulation kapil new
Coronary circulation kapil newCoronary circulation kapil new
Coronary circulation kapil new
 
CVS Part 2-1.ppt
CVS  Part 2-1.pptCVS  Part 2-1.ppt
CVS Part 2-1.ppt
 
2 systemic circulation.pptx
2 systemic circulation.pptx2 systemic circulation.pptx
2 systemic circulation.pptx
 
cardiovascular physiology based on Ganong's
cardiovascular physiology based on Ganong'scardiovascular physiology based on Ganong's
cardiovascular physiology based on Ganong's
 
Circulation
CirculationCirculation
Circulation
 
Arterial pressure
Arterial pressureArterial pressure
Arterial pressure
 
Hemodynamic principles ms limu monday 2017
Hemodynamic principles ms limu monday 2017Hemodynamic principles ms limu monday 2017
Hemodynamic principles ms limu monday 2017
 

Más de Vishwanath Hesarur

Más de Vishwanath Hesarur (18)

Treatment strategies in patients with statin intolerance
Treatment strategies in patients with statin intoleranceTreatment strategies in patients with statin intolerance
Treatment strategies in patients with statin intolerance
 
The age, creatinine, and ejection fraction score to risk
The age, creatinine, and ejection fraction score to riskThe age, creatinine, and ejection fraction score to risk
The age, creatinine, and ejection fraction score to risk
 
Riociguat for the treatment of pah
Riociguat for the treatment of pahRiociguat for the treatment of pah
Riociguat for the treatment of pah
 
Radiation dose reduction
Radiation dose reduction Radiation dose reduction
Radiation dose reduction
 
Pre hospital reduced-dose fibrinolysis followed by pci
Pre hospital reduced-dose fibrinolysis followed by pciPre hospital reduced-dose fibrinolysis followed by pci
Pre hospital reduced-dose fibrinolysis followed by pci
 
Nstemi
NstemiNstemi
Nstemi
 
Monocyte chemoattractant protein 1
Monocyte chemoattractant protein 1Monocyte chemoattractant protein 1
Monocyte chemoattractant protein 1
 
Energy drink
Energy drinkEnergy drink
Energy drink
 
Dissolution trial
Dissolution trialDissolution trial
Dissolution trial
 
Defer stemi
Defer stemiDefer stemi
Defer stemi
 
Cvs & t2 dm
Cvs & t2 dmCvs & t2 dm
Cvs & t2 dm
 
CHRONIC ASPIRIN AND STATIN THERAPY IN PATIENTS WITH IMPAIRED RENAL FUNCTION A...
CHRONIC ASPIRIN AND STATIN THERAPYIN PATIENTS WITH IMPAIRED RENAL FUNCTIONA...CHRONIC ASPIRIN AND STATIN THERAPYIN PATIENTS WITH IMPAIRED RENAL FUNCTIONA...
CHRONIC ASPIRIN AND STATIN THERAPY IN PATIENTS WITH IMPAIRED RENAL FUNCTION A...
 
Bivalirudin in acute coronary syndromes and percutaneous coronary
Bivalirudin in acute coronary syndromes and percutaneous coronaryBivalirudin in acute coronary syndromes and percutaneous coronary
Bivalirudin in acute coronary syndromes and percutaneous coronary
 
CARDIOVASCULAR DISEASE AND DIABETES
CARDIOVASCULAR DISEASE AND DIABETESCARDIOVASCULAR DISEASE AND DIABETES
CARDIOVASCULAR DISEASE AND DIABETES
 
ENDOMYOCARDIAL FIBROSIS
ENDOMYOCARDIAL FIBROSISENDOMYOCARDIAL FIBROSIS
ENDOMYOCARDIAL FIBROSIS
 
TOTAL ANOMALOUS PULMONARY VENOUS CONNECTION (TAPVC)
TOTAL ANOMALOUS PULMONARY VENOUS CONNECTION (TAPVC)TOTAL ANOMALOUS PULMONARY VENOUS CONNECTION (TAPVC)
TOTAL ANOMALOUS PULMONARY VENOUS CONNECTION (TAPVC)
 
Cardiac transplantation
Cardiac transplantationCardiac transplantation
Cardiac transplantation
 
Truncus Arteriosus
Truncus Arteriosus Truncus Arteriosus
Truncus Arteriosus
 

Último

Asymmetry in the atmosphere of the ultra-hot Jupiter WASP-76 b
Asymmetry in the atmosphere of the ultra-hot Jupiter WASP-76 bAsymmetry in the atmosphere of the ultra-hot Jupiter WASP-76 b
Asymmetry in the atmosphere of the ultra-hot Jupiter WASP-76 b
Sérgio Sacani
 
development of diagnostic enzyme assay to detect leuser virus
development of diagnostic enzyme assay to detect leuser virusdevelopment of diagnostic enzyme assay to detect leuser virus
development of diagnostic enzyme assay to detect leuser virus
NazaninKarimi6
 
Human genetics..........................pptx
Human genetics..........................pptxHuman genetics..........................pptx
Human genetics..........................pptx
Silpa
 
biology HL practice questions IB BIOLOGY
biology HL practice questions IB BIOLOGYbiology HL practice questions IB BIOLOGY
biology HL practice questions IB BIOLOGY
1301aanya
 
Porella : features, morphology, anatomy, reproduction etc.
Porella : features, morphology, anatomy, reproduction etc.Porella : features, morphology, anatomy, reproduction etc.
Porella : features, morphology, anatomy, reproduction etc.
Silpa
 

Último (20)

Asymmetry in the atmosphere of the ultra-hot Jupiter WASP-76 b
Asymmetry in the atmosphere of the ultra-hot Jupiter WASP-76 bAsymmetry in the atmosphere of the ultra-hot Jupiter WASP-76 b
Asymmetry in the atmosphere of the ultra-hot Jupiter WASP-76 b
 
development of diagnostic enzyme assay to detect leuser virus
development of diagnostic enzyme assay to detect leuser virusdevelopment of diagnostic enzyme assay to detect leuser virus
development of diagnostic enzyme assay to detect leuser virus
 
FAIRSpectra - Enabling the FAIRification of Analytical Science
FAIRSpectra - Enabling the FAIRification of Analytical ScienceFAIRSpectra - Enabling the FAIRification of Analytical Science
FAIRSpectra - Enabling the FAIRification of Analytical Science
 
PSYCHOSOCIAL NEEDS. in nursing II sem pptx
PSYCHOSOCIAL NEEDS. in nursing II sem pptxPSYCHOSOCIAL NEEDS. in nursing II sem pptx
PSYCHOSOCIAL NEEDS. in nursing II sem pptx
 
Chemistry 5th semester paper 1st Notes.pdf
Chemistry 5th semester paper 1st Notes.pdfChemistry 5th semester paper 1st Notes.pdf
Chemistry 5th semester paper 1st Notes.pdf
 
module for grade 9 for distance learning
module for grade 9 for distance learningmodule for grade 9 for distance learning
module for grade 9 for distance learning
 
Zoology 5th semester notes( Sumit_yadav).pdf
Zoology 5th semester notes( Sumit_yadav).pdfZoology 5th semester notes( Sumit_yadav).pdf
Zoology 5th semester notes( Sumit_yadav).pdf
 
GBSN - Microbiology (Unit 1)
GBSN - Microbiology (Unit 1)GBSN - Microbiology (Unit 1)
GBSN - Microbiology (Unit 1)
 
Locating and isolating a gene, FISH, GISH, Chromosome walking and jumping, te...
Locating and isolating a gene, FISH, GISH, Chromosome walking and jumping, te...Locating and isolating a gene, FISH, GISH, Chromosome walking and jumping, te...
Locating and isolating a gene, FISH, GISH, Chromosome walking and jumping, te...
 
300003-World Science Day For Peace And Development.pptx
300003-World Science Day For Peace And Development.pptx300003-World Science Day For Peace And Development.pptx
300003-World Science Day For Peace And Development.pptx
 
Proteomics: types, protein profiling steps etc.
Proteomics: types, protein profiling steps etc.Proteomics: types, protein profiling steps etc.
Proteomics: types, protein profiling steps etc.
 
Molecular markers- RFLP, RAPD, AFLP, SNP etc.
Molecular markers- RFLP, RAPD, AFLP, SNP etc.Molecular markers- RFLP, RAPD, AFLP, SNP etc.
Molecular markers- RFLP, RAPD, AFLP, SNP etc.
 
Use of mutants in understanding seedling development.pptx
Use of mutants in understanding seedling development.pptxUse of mutants in understanding seedling development.pptx
Use of mutants in understanding seedling development.pptx
 
Human genetics..........................pptx
Human genetics..........................pptxHuman genetics..........................pptx
Human genetics..........................pptx
 
Bhiwandi Bhiwandi ❤CALL GIRL 7870993772 ❤CALL GIRLS ESCORT SERVICE In Bhiwan...
Bhiwandi Bhiwandi ❤CALL GIRL 7870993772 ❤CALL GIRLS  ESCORT SERVICE In Bhiwan...Bhiwandi Bhiwandi ❤CALL GIRL 7870993772 ❤CALL GIRLS  ESCORT SERVICE In Bhiwan...
Bhiwandi Bhiwandi ❤CALL GIRL 7870993772 ❤CALL GIRLS ESCORT SERVICE In Bhiwan...
 
PATNA CALL GIRLS 8617370543 LOW PRICE ESCORT SERVICE
PATNA CALL GIRLS 8617370543 LOW PRICE ESCORT SERVICEPATNA CALL GIRLS 8617370543 LOW PRICE ESCORT SERVICE
PATNA CALL GIRLS 8617370543 LOW PRICE ESCORT SERVICE
 
biology HL practice questions IB BIOLOGY
biology HL practice questions IB BIOLOGYbiology HL practice questions IB BIOLOGY
biology HL practice questions IB BIOLOGY
 
GBSN - Microbiology (Unit 3)
GBSN - Microbiology (Unit 3)GBSN - Microbiology (Unit 3)
GBSN - Microbiology (Unit 3)
 
Porella : features, morphology, anatomy, reproduction etc.
Porella : features, morphology, anatomy, reproduction etc.Porella : features, morphology, anatomy, reproduction etc.
Porella : features, morphology, anatomy, reproduction etc.
 
Exploring Criminology and Criminal Behaviour.pdf
Exploring Criminology and Criminal Behaviour.pdfExploring Criminology and Criminal Behaviour.pdf
Exploring Criminology and Criminal Behaviour.pdf
 

FRACTIONAL FLOW RESERVE

  • 1. FRACTIONAL FLOW RESERVE DR VISHWANATH HESARUR SENIOR RESIDENT DEPT OF CARDIOLOGY JNMC, BELGAUM.
  • 2. CORONARY BLOOD FLOW AND MYOCARDIAL ISCHEMIA UNIQUE FEATURES OF CORONARY BLOOD FLOW • Phasic flow • Transmural flow • Extravascular compression • Oxygen Extraction
  • 3. Phasic flow • Coronary perfusion – intermittent rather than continuous
  • 4. Determinants of Myocardial Oxygen Consumption • In contrast to most other vascular beds, myocardial oxygen extraction is near-maximal at rest, averaging 60% to 80% of arterial oxygen content. So it might increase to maximum 90 % after heavy exercise. • Thus because of high resting tissue extraction of oxygen, increase in the myocardial oxygen consumption ( MVo2)are primarly met by a proportional increase in coronary blood flow. • The major determinants of MVo2 are heart rate, systolic pressure (or myocardial wall stress), and left ventricular (LV) contractility. • A twofold increase in any of these individual determinants of MVo2 requires an approx 50% increase in coronary blood flow.
  • 5. • Coronary blood flow at rest is Approx 250ml/min. • Myocardium will regulate its own blood flow between perfusion pressure of 40 to 140 mmhg, beyond this is pressure dependent. Autoregulation • Regional coronary blood flow remains constant as coronary artery pressure is reduced below aortic pressure over a wide range when the determinants of myocardial oxygen consumption are kept constant. • When pressure falls to the lower limit of autoregulation, coronary resistance arteries are maximally vasodilated to intrinsic stimuli, and flow becomes pressure-dependent, resulting in the onset of subendocardial ischemia. • The ability to increase flow above resting values in response to pharmacologic vasodilation is termed coronary flow reserve.
  • 6. • Transmural variations in the lower autoregulatory pressure limit, which result in increased vulnerability of the subendocardium to ischemia. • Subendocardial flow occurs primarily in diastole and begins to decrease below a mean coronary pressure of 40 mm Hg. • By contrast, subepicardial flow occurs throughout the cardiac cycle and is maintained until coronary pressure falls below 25 mm Hg. • This difference arises from – Increased oxygen consumption in the subendocardium. – Higher resting flow rates – Increased sensitivity to systolic compressive affects ie subendocardial flow occurs only in diastole. • The transmural difference in the lower autoregulatory pressure limit results in vulnerability of the subendocardium to ischemia in the presence of a coronary stenosis.
  • 7.
  • 8.
  • 9. Determinants of Coronary Vascular Resistance • The resistance to coronary blood flow can be divided into three major components • R1 ( Epicardial arteries )- Under normal circumstances, there is no measurable pressure drop in the epicardial arteries, indicating negligible conduit resistance. • R2 ( Microcirculatory resistance arteries & arteriole (20 to 400 μm in diameter)- distributed throughout the myocardium & respond to physical forces (intraluminal pressure and shear stress), as well as the metabolic needs of the tissue. • R3 (Extravascular compressive resistance)- During systole, cardiac contraction raises the extravascular pressure to values equal to LV pressure at the subendocardium. This declines to values near pleural pressure at the subepicardium. • The increased effective back pressure during systole produces a time varying reduction in the driving force for the coronary flow that impedes the coronary flow to subendocardium. • In heart failure compressive effects from elevated ventricular diastolic pressures also impede perfusion via passive compression by increasing extra vascular tissue pressure during diastole.
  • 10. Physiological assesment of coronary artery stenosis • The physiologic assessment of stenosis severity is a critical component of the management of patients with obstructive epicardial CAD. • Stenosis in the epicardial artery result in reduced perfusion pressure , arterioles downstream dilate to maintain normal resting flow . • As stenosis progress, arteriolar dilatation becomes chronic, decreasing potential to augment flow and thus reduce coronary flow reserve. • As CFR approaches to 1, any further decrease in perfusion pressure or increase in MV02 result in ischemia.
  • 11. • The total pressure drop across a stenosis is governed by three hydrodynamic factors — viscous losses, separation losses, and turbulence.
  • 12. The Coronary Pressure–Flow Relationships • Myocardial ischemia results from an imbalance between myocardial oxygen supply and demand. • Coronary blood flow provides the needed oxygen supply for any given myocardial oxygen demand and normally increases automatically from a resting level to a maximum level in response to increases in myocardial oxygen demand from exercise and neurohumoral or pharmacological hyperemic stimuli. • This increase from baseline to maximal flow has been termed coronary flow reserve (CFR).
  • 13. • Blood flow has 3 major resistance components: the epicardial vessel (R1), the small arteries and arterioles (R2), and the intramyocardial capillary system (R3). • When coronary reserve is normal, these 3 resistances are assumed to be functioning normally. • In patients without atherosclerosis, the large epicardial vessel resistance (R1) is trivial. • Arteries with diameters 400 um have only minimal resistance. • Adjustment of coronary resistance occurs principally at the R2 resistance (vessels 400 um in diameter) and is due to the integrated action of several control mechanisms. • Across a normal epicardial artery, supplying normal myocardium, coronary blood flow can increase 3-fold in adults.
  • 14. • Autoregulation automatically maintains the basal flow at a constant level in response to changing pressure and oxygen demand. • Atherosclerotic narrowings produce epicardial vessel resistance and, after a critical reduction in vessel lumen area, can abolish not only coronary reserve but also autoregulation, thus reducing resting coronary blood flow. • Coupled with reduced flow is the loss of pressure distal to a stenosis.
  • 15. • The resistance to flow through a stenosis caused by viscous friction, flow separation, turbulence, and eddies at the site of the stenosis results in energy loss. • Energy loss produces pressure loss distal to the stenosis and thus a pressure gradient across the narrowed segment (Figure 1).
  • 16. • The pressure loss or gradient increases with increasing coronary flow along a quadratic pressure drop–flow relationship of the specific coronary stenosis
  • 17. • In vessels without a stenosis, the pressure–flow curve of maximal vasodilation is linear in the physiological pressure range .
  • 18. • However, when a stenosis is present, the maximal flow at any given arterial pressure is lower. • In this setting, the coronary pressure–flow line at maximum vasodilation is no longer straight but curvilinear because stenosis resistance is flow dependent. • The clinical significance of these observations is that 2 nearly identical angiographic stenoses (eg, 60% diameter narrowing) can have a dramatically different clinical impact for the patient. • One stenosis would limit flow for increasing demand and would produce angina, whereas the other would be angiographically apparent but would remain clinically unimportant
  • 19. Coronary Pressure and Fractional Flow Reserve • Myocardial perfusion pressure, normally the diastolic coronary pressure, equals aortic pressure minus the left ventricular diastolic pressure or central venous pressure. • Across normal coronary arteries, aortic pressure is transmitted completely, without appreciable pressure loss even to the most distal regions. • As noted earlier, the distal coronary pressure in arteries with an atherosclerotic narrowing is decreased in relationship to the degree of stenosis resistance. • Pijls et al related the distal coronary pressure to the ischemic potential of a stenosis by calculating a value called the fractional flow reserve (FFR).
  • 20. • By taking the ratio of the coronary pressure measured distal to the stenosis to aortic pressure as the normal perfusion pressure (distal coronary pressure/aortic pressure) and obtaining these measurements when the microvascular resistance was minimal and assumed to be constant (that is, at maximal hyperemia), the percentage of normal coronary flow, or a fraction of normal flow (ie, FFR), can be calculated. • The FFR measures the maximum achievable myocardial blood flow in the presence of a coronary artery stenosis as a percentage of the maximum blood flow in the hypothetical case of a completely normal artery
  • 21. • FFR model assumes that under maximum arterial vasodilation, the resistance of the myocardium is minimal and constant across different myocardial vascular beds, and thus blood flow to the myocardium is proportional to the driving pressure (myocardial perfusion pressure). • FFR can be derived separately for the myocardium, for the epicardial coronary artery, and for the collateral supply. • Calculations of myocardial, coronary, and collateral FFR from pressure measurements taken during maximal arterial vasodilation (ie, hyperemia) are as follows:
  • 22. • The FFR is simplified to Pd/Pa given the assumption that Pv is negligible relative to Pa.
  • 23.
  • 24. • An FFR value of 0.6 means that the maximum myocardial flow across the stenosis is only 60% of what it should be without the stenosis. • An FFR of 0.9 after percutaneous coronary intervention (PCI) means that the maximum flow to the myocardium is 90% that of a completely normal vessel.
  • 25. • FFR has a normal value of 1.0 for every patient and every coronary artery. • An FFR 0.75 is associated with inducible ischemia (specificity, 100%), whereas a value 0.80 indicates absence of inducible ischemia in the majority of patients (sensitivity, 90%).
  • 26. Fractional Flow Reserve • Based on the principle that the distal coronary pressure measured during vasodilation is directly proportional to maximum vasodilated perfusion. • FFR is defined as the ratio of maximum blood flow in a stenotic artery to maximum blood flow in the same artery if there were no stenosis. • FFR is simply calculated as a ratio of mean pressure distal to a stenosis (Pd) to the mean pressure proximal stenosis, that is the mean pressure in the aorta (Pa), during maximal hyperaemia.
  • 27.
  • 28. LIMITATIONS OF CORONARY ANGIOGRAPHY – Interpretation is highly subjective – CAG provides a 2–dimentional view of a 3-dimensional lumen. – Severity of a stenotic lesion is reported in comparison to a normal reference segment . This is particularly fallacious in case of diffuse disease. – CAG is a lumenography & does not provide information regarding vessel wall & extent of positive or negative remodeling. – An ecentric stenosis has varying appearance of severity in different views. The length, size and severity of a lesion & its relationship with the vessel wall can affect the coronary flow. – Several artifacts contribute to the disparity in interpretation like vessel foreshortening, overlapping vessels, calcification & contrast streaming.
  • 29. TECHNIQUE Catheter • Diagnostic catheters can not be used to measure FFR - pressure measurements can be inaccurate & the wire manipulation is met with friction due to smaller internal diameters compared to guide catheters. • The main advantage of using guide catheters is that PCI is immediately possible if required. • Guide catheter with Side holes should not be used – It can create a false gradient between the side holes & the tip of the guide catheter creating a false Positive FFR. – Pharmacological vasodilatory agents may be flushed into the aorta instead of the coronary artery.
  • 30. Pressure Wire • Two pressure wires are available namely PressureWire ( st Jude medical, MN, USA) & Volcano WaveWire ( Volcano Inc, CA,USA) • Both have the pressure sensor (solid-state (electronic) sensor) located at the junction of the radiopaque & radiolucent part of the wire, 30 mm from the tip. • The wires are 0.014-inch (0.33-mm) floppy- tipped guide wire
  • 31. 36 PressureWire® The distal pressure in the coronary artery is measured by a tiny sensor located 3 cm from the tip of an 0.014” guidewire, called PressureWire®.
  • 33. Maximal Hyperaemia • Epicardial & resistance arteries have to be vasodilated. • Epicardial vessels are dilated using a bolus of 100-200 mcg of intracoronary nitroglycerine at least 30 seconds before the first measurement. • Hyperaemia is induced in the resistance vessels using adenosine ( IC or IV ) or papaverine ( IC )
  • 34. IV vs IC PHARMACOLOGIC HYPEREMIC AGENTS
  • 35. Maximum Hyperemia Horizontal Pd/Pa line: Steady State and likely Maximum Hyperemia
  • 36. Anticoagulation • Standard protocols for anticoagulation should be followed. • Heparin is administered according to body weight to maintain an ACT of at least 250. • Display • The pressure wire is connected to an interface ( Analyzer Express, St Jude medical inc. or combomap, volcano Inc.) which shows the mean Aortic pressure (Pa) & the mean pressure at the tip of the guide wire (Pd) simultaneously & provides a FFR value immediately.
  • 37. 42 RadiAnalyzer® PressureWire® is attached to RadiAnalyzer®, an interface which makes the FFR calculations automatically during the procedure. It displays both aortic and distal pressure wave forms. Cathlab recording system PressureWire AO transducer IBPinput FFR
  • 38. Precautions • Guiding catheter should not have side holes • Introducer needle should be removed before equalising or taking measurements. • Equalise the pressure measured by the pressure wire & guiding catheter. • Height of the transducer should be adjusted to the patients heart level. • Appropriate dose & route of pharmacological agents to achieve maximal hyperaemia is essential to obtain accurate results • Use central vein for IV adenosine.
  • 39. Pressure Measurement Step 1: Zero the Pressure System to the Atmosphere Step 2: Insert the Pressure Sensor Guide Wire Into the Guide and Equalize the 2 Pressures Step 3: Advance the Pressure Wire Sensor Distal to the Region of Interest Step 4: Induce Maximal Hyperemia Step 5: Wire Pullback to Check for Signal Drift
  • 40. 0 100 50 Pa = Guiding Catheter Pd = Pressure Wire Pressure Monitoring Guide Wire
  • 41. UNIQUE FEATURES OF FFR • Normal value of 1 irrespective of the patient , artery or vascular bed. It is independent of gender & other factors like DM & HTN • Well defined cut-off values : – FFR values ≤ 0.75 is invariably associated with inducible ischemia (sensitivity 88%, specificity 100%, positive predictive value 100% & overall accuracy 93%) – FFR ≥0.80 is usually not associated with inducible ischemia. – The gray zone of 0.75 to 0.80 spans over a small range of FFR values. • Systemic haemodynamics like heart rate , blood pressure & LV contractility do not affect the value of FFR since the value of Pd & Pa are taken simultaneously. • Reproducibility : FFR is reproducible since the microvasculature has the capacity to vasodilate the same extent repeatedly.
  • 42. • Contribution of collateral vessels is taken in to account. The pressure distal to the stenosis is influenced by antegrade flow & retrograde flow & is therefore influenced by a stenotic vessel supplied by collateral & a stenotic vessel giving collaterals to a more severely stenosed vessel. • Spatial resolution – During maximal hyperaemia, pulling back the pressure wire can provide an instantaneous measure of the signifance of a particular segment of the coronary artery with a spatial resolution of a few millimeters. – It therefore provides a per segment analysis of the coronary artery. – This is especially useful in case of sequential stenosis to determine the stenosis with the maximum haemodynamic significance.
  • 43. • Relation between FFR & viable myocardium : – If a stenotic vessel supplies a larger viable myocardial mass, there will be larger hyperaemic flow during maximal vasodilation resulting in a greater gradient between Pd & Pa & thus , a lower value of FFR. – Therefore , the haemodynamic significance of a lesion is dependent on its perfusion territory.
  • 44. APPLICATIONS OF FFR IN SPECIFIC SUBSETS Intermediate lesions • Intermediate lesions with a FFR of ≥ 0.80 can be safely defered. • The DEFER study has shown that patients with single vessel stenosis and FFR >0.75 who did not undergo PCI had excellent outcomes. • The risk of cardiac death or MI related to the stenosis was < 1% per year and was not reduced with PCI. • In contrast, patients with single-vessel stenosis and FFR <0.75 are 5× more likely to experience cardiac death or MI within 5 years, despite undergoing revascularization.
  • 45.
  • 46.
  • 47.
  • 48.
  • 49. • Deferral of revascularization for single-vessel stenoses according to the FFR value is safe regardless of the stenosis location. • Muller et al showed that medical treatment of patients with proximal left anterior descending stenoses and FFR >0.80 had excellent 5-year outcomes. • Even for patients with small coronary arteries (diameter <2.8 mm), FFR can safely determine stenoses that necessitate revascularization.
  • 50. • Physiologic and Anatomical Evaluation Prior to and After Stent Implantation in Small Coronary Vessels (PHANTOM) trial, – 60 patients with small coronary arteries underwent FFR. – 56 of the 60 patients had undergone IVUS. – Patients were stratified according to FFR (<0.75 and >0.75). – The group with FFR <0.75 underwent revascularization. – At 1 year, there was no occurrence of MI or death in either group. – In patients with FFR <0.75, 24% underwent a repeat PCI, but only 2.6% of patients with FFR >0.75 underwent revascularization. – Overall, there was no correlation between FFR and IVUS.
  • 51.
  • 52. Multivessel Coronary Artery Disease • FFR has a major impact on the revascularisation strategy in multivessel disease . • In patients who have triple vessel disease , FFR may demonstrate haemodynamically significant stenosis of only two vessels. • Conversely , a patient with apparently one or two vessel disease may have a haemodynamic significant lesion in LM artery or in all three vessels. • This can affect the decision of PCI versus surgical revascularisation & also the number of stents used during PCI. • The FAME study showed a reduced rate of mortality & MI after 2 yrs in the subset with FFR guided PCI, in patients with multivessel disease.
  • 53. Ref. NEJM Vol 360, No 3, pp 213-224. Slides courtesy Nico H J Pijls. FAME study: Study Population The FAME study was designed to reflect daily practice in performing PCI in patients with multivessel disease Inclusion criteria: • ALL patients with multivessel disease • At least 2 stenoses ≥ 50% in 2 or 3 major epicardial coronary artery disease, amenable for stenting Exclusion criteria: • Left main disease or previous bypass surgery • ST-elevation MI with CK > 1000 U/l within last 5 days • extremely tortuous or calcified coronary arteries Note: patients with previous PCI were not excluded
  • 54.
  • 55.
  • 56.
  • 57.
  • 58.
  • 59.
  • 60. • CONCLUSIONS: Routine measurement of FFR in patients with multivessel disease (MVD) who are undergoing PCI with drug-eluting stents (DES) significantly improves outcomes at 1 year by reducing MACE (composite rate of death, nonfatal myocardial infarction, and repeat revascularization)
  • 61. FAME II: Fractional Flow Reserve-Guided Percutaneous Coronary Intervention plus Optimal Medical Treatment versus Optimal Medical Treatment Alone in Patients with Stable Coronary Artery Disease
  • 62. 73% 50% randomly assigned to FU27% Registry When all FFR > 0.80 (n=332) MT Randomized Trial At least 1 stenosis with FFR ≤ 0.80 (n=888) Randomization 1:1 PCI + MT MT Follow-up after 1, 6 months, 1, 2, 3, 4, and 5 years De Bruyne B, et al. N Engl J Med. 2012 Sep13;367(11):991-1001. FAME 2 Study Flow Chart Stable CAD patients scheduled for 1, 2 or 3 vessel DES-PCI N = 1220 FFR in all target lesions
  • 63. Cumulativeincidence(%) FAME 2: Primary Outcomes Death, MI, Urgent Revascularization 30 25 20 15 10 5 0 441 447 166 414 414 156 370 388 145 322 351 133 283 308 117 253 277 106 220 243 93 192 212 74 162 175 64 127 155 52 100 117 41 70 92 25 37 53 13 MT PCI+MT Registry No. at risk 0 1 2 3 4 5 6 7 8 9 10 11 12 Months after randomization PCI+MT vs. MT: PCI+MT vs. Registry: MT vs. Registry: HR 0.32 (0.19-0.53); p<0.001 HR 1.29 (0.49-3.39); p=0.61 HR 4.32 (1.75-10.7); p<0.001 De Bruyne B,et al. N Engl J Med. 2012 Sep 13;367(11):991-1001.
  • 64. FAME 2: Primary Outcomes Primary Endpoint Death Myocardial Infarction Urgent Revascularization Free from Angina (1 month) FFR-Guided PCI (n=447) 4.3% 0.2% 3.4% 1.6% 89% MT (n=441) 12.7% 0.7% 3.2% 11.1% 71% P-Value <0.001 0.31 0.89 <0.001 <0.001 De Bruyne B,et al. N Engl J Med. 2012 Sep 13;367(11):991-1001.
  • 65. FAME 2 TRIAL • Conclusion • In patients with stable coronary artery disease and at least one stenosis with an FFR≤0.80, OMT alone was associated with a more than fourfold larger hazard of major adverse cardiac events than FFR- guided PCI with drug-eluting stents plus OMT. • In contrast, in patients with hemodynamically non- significant stenoses (FFR>0.80), OMT alone was associated with a favourable clinical outcome.
  • 66. Left-Main Coronary Artery Disease • Left main coronary artery poses certain challenges which make the interpretation of CAG & severity of stenosis difficult. – Greater inter-observer variability – Under-estimation of functional significance since it supplies a large myocardial territory – Diffuse atherosclerosis in a short LMCA results in absence of a reference segment to judge the significance of a lesion – Spilling of contrast medium in to the aorta – Overlapping the catheter with the LMCA – Non – invasive testing may lead to false negative results since reduced tracer uptake in all vascular territories leading to balanced ischemia. – FFR has been found to be safe in guiding LMCA revascularisation in several studies & is associated with improved outcomes.
  • 67.
  • 68. Tandem Lesions • Tandem lesions are defined as 2 separate lesions with >50% stenosis each in the same coronary artery, separated by an angiographically normal segment. • If the FFR is<0.75, Hirota et al suggested performing PCI for the stenosis that showed marked narrowing first and then repeating the FFR measurement. • If the FFR remains <0.75, the other stenosis was revascularized as well; in contrast, if the FFR value of the first lesion increased after PCI to >0.75, then the second lesion was treated only medically
  • 69. Treat lesion 2, Final FFR J Am Coll Cardiol Intv. 2012;5(10):1013-1018. Considerations for Serial lesions Pre FFR (1+2) with pullback Lesion 1 large dP, Stent Recheck FFR
  • 70. • Lesion with largest pressure drop was stented first (116 total stents, 70 proximal, 46 distal) • Strategy not clearly stated but seems like goal was to achieve post stent FFR > 0.80 • Revascularization deferred in 61% lesions • ≥2 stents deployed in only 18% vessels N=298 Lesions, at least 20 mm apart, either chronic CAD or no Kim et al. J Am Coll Cardiol Intv 2012;5:1013-8 FFR Guided PCI of Serial Lesions N=131 Patients with multiple 40-70% stenoses, 2 centers
  • 71. Bifurcation lesions • Bifurcation lesions are particularly difficult to evaluate by angiography. • After stenting the main vessel, the side branch appears pinched which is grossly overestimated by angiography • Koo et al showed that kissing balloon dilatation of the ostial side branch lesions with FFR < 0.75 only , resulted to a FFR > 0.75 in 95% patients after 6 months. • If the FFR of an apparently pinched side branch is >0.75, it can safely be left alone.
  • 72. FFR in Bifurcation Disease N = 110 patients with FFR guided bifurcation PCI with DES compared with 110 matched angiographic guided bifurcation PCI Koo et al., European Heart Journal 2008 29(6):726-732
  • 73. FFR in Bifurcation Disease N = 26 patients with FFR guided side branch PCI with DES with baseline and follow up FFR Koo et al., European Heart Journal 2008 29(6):726-732
  • 74. Post stenting • Nico H.J. Pijls at al showed that FFR measured after stenting should be >0.90 & is an independent predictor of 6 month mortality. • The registry was performed in 750 patients in 15 hospitals in 8 countries (5 centers in the United States, 5 centers in Europe, and 5 centers in Asia).
  • 75. Coronary Pressure Measurement After Stenting Predicts Adverse Events at Follow-Up A Multicenter Registry, (Circulation. 2002;105:2950- 2954.)
  • 76. CABG conduit patency • 20-25 % of grafts done to physiologically nonsignificant lesions ( FFR > 0.80) were found to be occluded at 1 yr. • This occurs because blood flow favors a path of lower resistance through the native vessel with a nonsignificant obstruction as compared to a vein graft. • Thus FFR can provide information about future graft patency & allows an appropriate selection of the vessel which should not be grafted
  • 77. Graft intervention • FFR can be used to determine the physiological significance of a lesion in a graft vessel. • The same cut off af ≤ 0.75 has been used in a small study comparing FFR to stress myocardial perfusion imaging with an acceptable specificity & negative predicitive value.
  • 78. PITFALLS OF FFR Hemodynamic Artifacts • Damped pressure waveforms. • Guide obstruction • Contrast media • Very small guide (<5F) • Pressure signal drift • Side holes and ostial ‘pseudostenosis’ Technical • loose connections • Improper zero • Calibration offset Anatomic • Extreme tortuosity • Inability to wire vessel • Spasm Mechanical Wire/artery impact Pharmacologic Inadequate hyperemia
  • 79. Effect of Wire Introducer
  • 80. Guiding catheter related • Small ostium, too large guiding catheter • Solve by dislodging guiding and using iv adenosine guiding in ostium guiding out ostium
  • 81. Impact of Catheter Size on Hyperemic Flow De Bruyne, et al. Cathet Cardiovasc Diagn 1994;33:145-152.
  • 82. Pd Pc FFR and Guidings with Side-Holes Pa Pressure recorded by guiding PaPc = When wedging of the catheter, withdraw guiding from ostium For flow or pressure measurements: NO SIDE-HOLES
  • 83. Side Holes Sensor proximal to side holes Guiding Catheter With Sides Holes
  • 84. Notch Notch No notch Drift Drift True Gradient Notch
  • 85.
  • 86.
  • 87.
  • 88. CONCLUSION • FFR strongly supports the concept of 'Functionally Complete Revascularisation', that is stenting of the physiologically significant ischemic stenosis & medical management of the non-ischemic stenosis . • In spite of the strong evidence favoring its use, FFR is still not used widely . • The application of FFR along with angiography combines two gold standard investigations to provide an all in one anatomical & physiological assessment of CAD. • Its application in various subsets of coronary artery anatomies make FFR an essential tool in the cath lab ,in decision making & improving outcomes of patients undergoing PCI.
  • 89.
  • 90.
  • 91. Coronary Flow and Flow Reserve • As stenosis severity increases, maximal coronary flow becomes attenuated and CFR decreases. • CFR is a combined measure of the capacity of the major resistance components (the epicardial coronary artery and supplied vascular bed) to achieve maximal blood flow in response to hyperemic stimulation.
  • 92. • A normal CFR implies that both the epicardial and minimally achievable microvascular bed resistances are low and normal. • However, when abnormal, CFR does not indicate which component is affected, thus limiting the clinical applicability of this measurement. • Although early studies in animals and patients suggested an absolute CFR of 3.5 to 5 in adult patients with chest pain syndromes and CAD risk factors undergoing cardiac catheterization with angiographically normal vessels, the normal CFR was 2.70 to 6 which suggests a degree of patient variability and microvascular disease.
  • 93. • In patients with essential hypertension and normal coronary arteries or in patients with aortic stenosis and normal coronary arteries, CFR may be reduced, in part because of myocardial hypertrophy and an abnormal microvasculature. • CFR can be altered by changes in either basal or hyperemic flow, which are influenced by hemodynamics, loading conditions, and contractility. • For example, tachycardia increases basal flow and decreases hyperemic flow, thus reducing CFR 10% for each 15-beat increase in heart rate.
  • 94. • Because CFR is a summed response of both the epicardial and microvascular flow, clinicians are reluctant to use CFR as the sole indicator of lesion significance except when it is normal. • To increase confidence in CFR as a measure of lesion severity, the determination of relative CFR (rCFR) has been proposed by Gould et al,3 who defined rCFR as the ratio of maximal flow in a coronary artery with stenosis (QS) to maximal flow in a normal coronary artery without a stenosis (QN). • It was shown that rCFR was independent of the aortic pressure and rate–pressure product and was well suited to assess the physiological significance of coronary stenoses when an adjacent nondiseased coronary artery was available • For invasive catheterization laboratory flow studies, rCFR was defined as the ratio of CFRtarget to CFRnormal reference vessel:
  • 95. • The normal range for rCFR is 0.8 to 1.0. • Because of the variability of CFR and limitations in patients with multivessel CAD, rCFR is not commonly used. • Likewise, rCFR relies on the assumption that the microvascular circulatory response is uniformly distributed among the myocardial beds; thus, rCFR is of no value in patients with myocardial infarction (MI) or left ventricular regional dysfunction or in patients in whom the microcirculatory responses may be heterogeneous (eg, those with myocardial fibrosis or asymmetric hypertrophy). • In clinical terms, CFR is best used to assess the microcirculation in the absence of epicardial artery narrowings. • CFR is not used to assess stenosis significance because of the influence of hemodynamics and the unknown impact of the microcirculation.
  • 96. Rentrop Grade of Collateral Filling • Rentrop et al. proposed the system below to grade collateral filling of recipient arteries: • Rentrop Grade 0 No visible filling of any collateral channels. • Rentrop Grade 1 Collateral filling of branches of the infarct related artery. • Rentrop Grade 2 Partial collateral filling of the epicardial segment of the infarct related artery . • Rentrop Grade 3 Complete collateral filling of the infarct related artery.
  • 97. Laminar flow • Laminar flow is the normal condition for blood flow throughout most of the circulatory system. • It is characterized by concentric layers of blood moving in parallel down the length of a blood vessel. • The highest velocity (Vmax) is found in the center of the vessel. • The lowest velocity (V=0) is found along the vessel wall. • The flow profile is parabolic once laminar flow is fully developed. This occurs in long, straight blood vessels, under steady flow conditions. • One practical implication of parabolic, laminar flow is that when flow velocity is measured using a Doppler flowmeter, the velocity value represents the average velocity of a cross-section of the vessel, not the maximal velocity found in the center of the flow stream. • The orderly movement of adjacent layers of blood flow through a vessel helps to reduce energy losses in the flowing blood by minimizing viscous interactions between the adjacent layers of blood and the wall of the blood vessel. • Disruption of laminar flow leads to turbulence and increased energy losses.
  • 98.
  • 99. Turbulent Flow • Generally in the body, blood flow is laminar. However, under conditions of high flow, particularly in the ascending aorta, laminar flow can be disrupted and become turbulent. • When this occurs, blood does not flow linearly and smoothly in adjacent layers, but instead the flow can be described as being chaotic. • Turbulent flow also occurs in large arteries at branch points, in diseased and narrowed (stenotic) arteries (see figure below), and across stenotic heart valves.
  • 100. • Turbulence increases the energy required to drive blood flow because turbulence increases the loss of energy in the form of friction, which generates heat. • When plotting a pressure- flow relationship (see figure to right), turbulence increases the perfusion pressure required to drive a given flow. • Alternatively, at a given perfusion pressure, turbulence leads to a decrease in flow.
  • 101. Viscosity of Blood • Viscosity is an intrinsic property of fluid related to the internal friction of adjacent fluid layers sliding past one another • This internal friction contributes to the resistance to flow. • The interactions between fluid layers depend on the chemical nature of the fluid, and whether it is homogeneous or heterogeneous in composition. • For example, water is a homogeneous fluid and its viscosity is determined by molecular interactions between water molecules. • Water behaves as a Newtonian fluid and therefore under non-turbulent conditions, its viscosity is independent of flow velocity (i.e., does not change with changes in velocity). • Although plasma is mostly water, it also contains other molecules such as electrolytes, proteins (especially albumin and fibrinogen), and other macromolecules. • Because of various molecular interactions between these many different components of plasma, it is not surprising that plasma has a higher viscosity than water. • In fact, plasma at 37°C is about 1.8-times more viscous than water at the same temperature; therefore, the relative viscosity of plasma (compared to water) is about 1.8.
  • 102. • The addition of formed elements to the plasma (red cells, white cells, and platelets) further increases the viscosity. • Of these formed elements, red cells have the greatest effect on viscosity under normal conditions. • As shown in the figure to the right in which whole blood viscosity is determined in vitro using a viscometer, an increase in red cell hematocrit leads to an increase in relative viscosity. • Note that the increase is non-linear, so that doubling hematocrit more than doubles the relative viscosity. • Therefore, blood viscosity strongly depends on hematocrit. • At a normal hematocrit of 40-45%, the relative viscosity of blood is 4-5. • Patients with a condition called polycythemia, which is a abnormal elevation in red cell hematocrit, have much higher blood viscosities. • This increases the resistance to blood flow and therefore increases the work of the heart and can impair organ perfusion. • Some patients with anemia have low hematocrits, and therefore reduced blood viscosities.
  • 103.
  • 104. • A second important factor that influences blood viscosity is temperature. • Just like molasses, when blood gets cold, it get "thicker" and flows more slowly. • Therefore, there is an inverse relationship between temperature and viscosity. • Viscosity increases about 2% for each degree centigrade decrease in temperature. • Normally, blood temperature does not change much in the body. However, if a person's hand is exposed to a cold environment and the fingers become cold, the blood temperature in the fingers will fall and viscosity increase, which together with sympathetic-mediated vasoconstriction will decrease blood flow in the cooled region. • When whole body hypothermia is induced in critical care or surgical situations, this will also lead to an increase in blood viscosity and therefore affect systemic hemodynamics and organ blood flow.
  • 105. • Unlike water, blood is non-Newtonian, meaning that viscosity is not independent of flow at all flow velocities. In fact, during conditions such as circulatory shock where microcirculatory flow in tissues is reduced because of decreased arterial pressure, low flow states can lead to several-fold increases in viscosity. Low flow states permit increased molecular interactions to occur between red cells and between plasma proteins and red cells. This can cause red cells to stick together and form chains of several cells (rouleau formation) within the microcirculation, which increases the blood viscosity.
  • 106. • If clotting mechanisms are stimulated in the blood, platelet aggregation and interactions with plasma proteins occur. This leads to entrapment of red cells and clot formation, which dramatically increase blood viscosity.
  • 107. • There is a microcirculatory phenomenon called the Fahraeus- Lindqvist effect that leads to a reduction in hematocrit in small arterioles (less than 200 microns in diameter) and capillaries relative to the hematocrit of large feed arteries. This decrease in hematocrit in these flow vessels reduces the relative blood viscosity in the small vessels, which helps to offset the increase in viscosity that can occur because of reduced velocity in these same vessels. The net effect of these changes is that blood flow in the microcirculation has a lower viscosity than what is predicted by in vitro blood viscometer measurements. In vivo measurements of blood viscosity were made in dog hindlimbs in 1933 by Whittaker and Winton (J. Physiol. 78:339, 1933). At a given arterial blood hematocrit, the relative viscosity of blood is much lower than predicted from in vitro experiments (compare figure at right with previous figure that used a viscometer).